News & Articles

Leftover pulp from grapes can be a nutritious powerhouse – possibly reducing risk from illness such cardiovascular disease and diabetes

The findings will allow manufacturers to identify whether their juices contain A. suci, which leads to spoilage

Compared to conventional bandages, the organo-hydrogel bandages keep wounded areas moist and cool leading to accelerated healing

This research will advance the utilization of wastes generated in agricultural systems for value-added carbon production and ultimately energy storage devices

Teams uses mathematical modelling study to guide preparations for future health strategies

A first of its kind study demonstrates voltage outside of biological cells, with potential implications for cardiovascular disease, cancer and fertility treatment

Join leading researchers online to explore the latest advances and common challenges in the field of breath biopsy

Awarded jointly to Benjamin List and David W.C. MacMillan "for the development of asymmetric organocatalysis"

New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions

This new oncology service supports unique in vitro investigations into the PK/PD relationship

Syukuro Manabe, Klaus Hasselmann and Giorgio Parisi honored for their groundbreaking contributions to our understanding of complex physical systems

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments

Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource

ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community

The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance